Mohit Butaney

8.3k total citations · 1 hit paper
68 papers, 2.7k citations indexed

About

Mohit Butaney is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Mohit Butaney has authored 68 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 17 papers in Surgery. Recurrent topics in Mohit Butaney's work include Lung Cancer Treatments and Mutations (22 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Renal cell carcinoma treatment (9 papers). Mohit Butaney is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Renal cell carcinoma treatment (9 papers). Mohit Butaney collaborates with scholars based in United States, Canada and Ireland. Mohit Butaney's co-authors include Pasi A. Jänne, David M. Jackman, Geoffrey R. Oxnard, Bruce E. Johnson, Lynette M. Sholl, Mizuki Nishino, Paul T. Kirschmeier, Melissa M. Messineo, Cloud P. Paweletz and Jason J. Luke and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Cell.

In The Last Decade

Mohit Butaney

65 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

2014 590 citations Geoffrey R. Oxnard, Cloud P. Paweletz et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohit Butaney United States	19	1.8k	1.5k	894	892	266	68	2.7k
Adrian G. Sacher Canada	29	2.0k 1.1×	1.7k 1.1×	1.0k 1.2×	809 0.9×	267 1.0×	153	3.1k
Mauro Zukin Brazil	13	2.8k 1.6×	2.4k 1.6×	519 0.6×	748 0.8×	158 0.6×	38	3.5k
Wenting Wu China	9	1.8k 1.0×	2.7k 1.8×	1.0k 1.1×	1.5k 1.7×	221 0.8×	23	4.0k
J. Corral Spain	26	2.5k 1.4×	2.3k 1.5×	457 0.5×	856 1.0×	121 0.5×	60	3.5k
John R. Goffin Canada	24	833 0.5×	988 0.7×	560 0.6×	765 0.9×	204 0.8×	72	2.3k
Yasushi Goto Japan	30	2.2k 1.2×	2.5k 1.7×	602 0.7×	854 1.0×	243 0.9×	246	3.8k
Paul T. Fanta United States	28	968 0.5×	1.1k 0.7×	1.2k 1.4×	617 0.7×	514 1.9×	73	2.5k
Kathryn P. Gray United States	22	1.0k 0.6×	959 0.6×	657 0.7×	622 0.7×	102 0.4×	75	2.0k
Purvish Parikh India	9	2.1k 1.2×	1.8k 1.2×	412 0.5×	521 0.6×	107 0.4×	21	2.6k
Maximilian J. Hochmair Austria	27	2.1k 1.2×	2.2k 1.5×	607 0.7×	731 0.8×	143 0.5×	215	2.9k

Countries citing papers authored by Mohit Butaney

Since Specialization

Citations

This map shows the geographic impact of Mohit Butaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohit Butaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohit Butaney more than expected).

Fields of papers citing papers by Mohit Butaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohit Butaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohit Butaney. The network helps show where Mohit Butaney may publish in the future.

Co-authorship network of co-authors of Mohit Butaney

This figure shows the co-authorship network connecting the top 25 collaborators of Mohit Butaney. A scholar is included among the top collaborators of Mohit Butaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohit Butaney. Mohit Butaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yuzhi, et al.. (2024). Assessment of the gender gap in urology industry payments: An Open Payments Program data analysis. Investigative and Clinical Urology. 65(4). 411–411. 1 indexed citations

Butaney, Mohit, et al.. (2024). Intermediate-Term Oncologic Outcome Assessment for Robot-Assisted Radical Prostatectomy: Comparing Retzius-Sparing with Standard Approach in a Randomized Control Cohort. Journal of Endourology. 38(6). 559–563. 3 indexed citations

Butaney, Mohit, Sabrina L. Noyes, Brian Seifman, et al.. (2024). Renal Mass Biopsy is Associated With Fewer Radical Nephrectomies for Benign or Indolent Disease, Particularly for T1b Renal Masses. Urology Practice. 12(1). 148–156. 1 indexed citations

Wang, Yuzhi, et al.. (2024). The evolving management of small renal masses. Nature Reviews Urology. 21(7). 406–421. 5 indexed citations

Butaney, Mohit, et al.. (2022). Robotic total and partial adrenalectomy: A step by step approach. SHILAP Revista de lepidopterología. 13. 100138–100138.

Gorin, Michael A., Anil K. Sood, Mohit Butaney, et al.. (2022). Impact of prostate biopsy technique on outcomes of the precision prostatectomy procedure. SHILAP Revista de lepidopterología. 4(1). e000122–e000122. 1 indexed citations

Butaney, Mohit, et al.. (2020). Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members. Urology. 139. 104–109. 3 indexed citations

Balasubramanian, Adithya, et al.. (2019). Patient Attitudes Toward Testicular Prosthesis Placement After Orchiectomy. American Journal of Men s Health. 13(4). 1818138907–1818138907. 8 indexed citations

Butaney, Mohit, Nannan Thirumavalavan, Dayron Rodríguez, Martin Gross, & Ricardo Munarriz. (2019). Current practice in the management of ischemic priapism: an anonymous survey of ISSM members. International Journal of Impotence Research. 31(6). 404–409. 9 indexed citations

10.

Sathianathen, Niranjan, Mohit Butaney, Connie Bongiorno, et al.. (2018). Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 22(1). 39–48. 18 indexed citations

11.

Sathianathen, Niranjan, et al.. (2018). Urinary Biomarkers in the Evaluation of Primary Hematuria: A Systematic Review and Meta-Analysis. Bladder Cancer. 4(4). 353–363. 30 indexed citations

12.

Calles, Antonio, Lynette M. Sholl, Scott J. Rodig, et al.. (2015). Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS -Mutant Lung Adenocarcinoma. Clinical Cancer Research. 21(12). 2851–2860. 86 indexed citations

13.

Tanizaki, Junko, Dalia Ercan, Marzia Capelletti, et al.. (2015). Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2. Cancer Research. 75(15). 3139–3146. 30 indexed citations

14.

Wilson, Frederick H., Cory M. Johannessen, Federica Piccioni, et al.. (2015). A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer. Cancer Cell. 27(3). 397–408. 130 indexed citations

15.

Oxnard, Geoffrey R., Cloud P. Paweletz, Yanan Kuang, et al.. (2014). Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA. Clinical Cancer Research. 20(6). 1698–1705. 590 indexed citations breakdown →

16.

Cardarella, Stephanie, Atsuko Ogino, Mizuki Nishino, et al.. (2013). Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(16). 4532–4540. 274 indexed citations

17.

Oxnard, Geoffrey R., Peter Lo, Mizuki Nishino, et al.. (2013). Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions. Journal of Thoracic Oncology. 8(2). 179–184. 261 indexed citations

18.

Sholl, Lynette M., Heather H. Sun, Mohit Butaney, et al.. (2013). ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas. The American Journal of Surgical Pathology. 37(9). 1441–1449. 135 indexed citations

19.

Cardarella, Stephanie, Taylor M. Ortiz, Victoria A. Joshi, et al.. (2012). The Introduction of Systematic Genomic Testing for Patients with Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(12). 1767–1774. 77 indexed citations

20.

Cheung, Hiu Wing, Jinyan Du, Jesse S. Boehm, et al.. (2011). Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non–Small Cell Lung Cancers. Cancer Discovery. 1(7). 608–625. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact